首页> 外文期刊>Drug Design, Development and Therapy >Time and dose relationships between schisandrin B- and schisandrae fructus oil-induced hepatotoxicity and the associated elevations in hepatic and serum triglyceride levels in mice
【24h】

Time and dose relationships between schisandrin B- and schisandrae fructus oil-induced hepatotoxicity and the associated elevations in hepatic and serum triglyceride levels in mice

机译:五味子乙素和五味子油诱导的小鼠肝毒性的时间和剂量关系以及小鼠肝脏和血清甘油三酸酯水平的相关升高

获取原文
       

摘要

Background: Schisandrin B (Sch B), a dibenzocyclooctadiene compound, is isolated from schisandrae fructus (SF). This study was conducted to compare the time- and dose-response between Sch B- and SF oil (SFO)-induced changes in hepatic and serum parameters in mice. Methods: Institute of Cancer Research (ICR) mice were given a single oral dose of Sch B (0.125–2 g/kg) or SFO (0.3–5 g/kg). Serum alanine aminotransferase (ALT) activity, hepatic malondialdehyde, and triglyceride (TG) levels were measured at increasing time intervals within 6–120 hours postdosing. Results: Serum ALT activity was elevated by 60%, with maximum effect (Emax) =45.77 U/L and affinity (KD) =1.25 g/kg at 48–96 hours following Sch B, but not SFO, treatment. Sch B and SFO treatments increased hepatic malondialdehyde level by 70% (Emax =2.30 nmol/mg protein and KD =0.41 g/kg) and 22% (Emax =1.42 nmol/mg protein and KD =2.56 g/kg) at 72 hours postdosing, respectively. Hepatic index was increased by 16%–60% (Emax =11.01, KD =0.68 g/kg) and 8%–32% (Emax =9.88, KD =4.47 g/kg) at 12–120 hours and 24–120 hours after the administration of Sch B and SFO, respectively. Hepatic TG level was increased by 40%–158% and 35%–85%, respectively, at 12–96 hours and 6–48 hours after Sch B and SFO treatment, respectively. The values of Emax and KD for Sch B/SFO-induced increase in hepatic TG were estimated to be 22.94/15.02 μmol/g and 0.78/3.03 g/kg, respectively. Both Sch B and SFO increased serum TG (up to 427% and 123%, respectively), with the values of Emax =5.50/4.60 mmol/L and KD =0.43/2.84 g/kg, respectively. Conclusion: The findings indicated that Sch B/SFO-induced increases in serum/hepatic parameters occurred in a time-dependent manner, with the time of onset being serum TG level < hepatic TG level < hepatic index < serum ALT activity. However, the time of recovery of these parameters to normal values varied as follow: serum TG level < hepatic TG level and liver injury < hepatic index. The Emax and affinity of Sch B on tissue/enzyme/receptor were larger than those of SFO.
机译:背景:二苯并环辛二烯化合物五味子素B(Sch B)是从五味子(SF)中分离出来的。进行这项研究以比较Sch B和SF油(SFO)诱导的小鼠肝脏和血清参数变化的时间和剂量反应。方法:癌症研究所(ICR)小鼠单次口服Sch B(0.125–2 g / kg)或SFO(0.3–5 g / kg)。在服药后6–120小时内,在增加的时间间隔内测量血清丙氨酸氨基转移酶(ALT)活性,肝丙二醛和甘油三酸酯(TG)的水平。结果:Sch B而非SFO治疗后48-96小时,血清ALT活性提高了60%,最大作用(Emax)= 45.77 U / L,亲和力(KD)= 1.25 g / kg。 Sch B和SFO治疗在72小时时使肝丙二醛水平分别提高了70%(Emax = 2.30 nmol / mg蛋白和KD = 0.41 g / kg)和22%(Emax = 1.42 nmol / mg蛋白和KD = 2.56 g / kg)后给药。在12–120小时和24–120小时时,肝指数分别提高了16%–60%(Emax = 11.01,KD = 0.68 g / kg)和8%–32%(Emax = 9.88,KD = 4.47 g / kg)分别由Sch B和SFO管理之后。 Sch B和SFO治疗后,分别在12–96小时和6–48小时,肝TG水平分别增加40%–158%和35%–85%。 Sch B / SFO引起的肝TG升高的Emax和KD值分别估计为22.94 / 15.02μmol/ g和0.78 / 3.03 g / kg。 Sch B和SFO均可提高血清TG(分别高达427%和123%),Emax值分别为5.50 / 4.60 mmol / L和KD = 0.43 / 2.84 g / kg。结论:研究结果表明,Sch B / SFO诱导的血清/肝参数升高呈时间依赖性,其发作时间为血清TG水平<肝TG水平<肝指数<血清ALT活性。但是,这些参数恢复到正常值的时间变化如下:血清TG水平<肝TG水平和肝损伤<肝指数。 Sch B对组织/酶/受体的Emax和亲和力大于SFO。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号